Featuring automated one-click functionality for capturing prostate volume, the AI-enabled software may help shorten workflows for prostate imaging, biopsies, and ultrasound-guided procedures.
An emerging artificial intelligence software may enable clinicians to quickly obtain automated measurements of prostate volume.
With the launch of Prostate Volume Assist, clinicians can ascertain prostate measurements and calculations with one click, according to GE HealthCare, the manufacturer of the software. The company said the Prostate Volume Assist can be beneficial with prostate imaging and ultrasound-guided procedures.
“Normally, clinicians determine prostate volume through a manual, repetitive process that requires measuring multiple dimensions and applying a mathematical formula,” said Fredrik Gran, head of innovation, surgical visualization and guidance, ultrasound at GE HealthCare. “Prostate Volume Assist uses artificial intelligence to automate this process with a single click, and yield results in less than two seconds. This technology provides an added level of support for (clinicians) to improve efficiencies in the workflow and enable precision care.”
GE HealthCare noted that Prostate Volume Assist will be accessible via the company’s bkActiv, bk3000/5000 and bkSpecto ultrasound modalities.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.